Two years follow up study with long-acting injectable risperidone in schizophrenia

被引：0
|
作者：
Chinchilla, A. [1 ]
Vega, M. [1 ]
Crespo, D. [1 ]
Yanez, R. [2 ]
Pando, F. [1 ]
Benitez, E. [1 ]
机构：
[1] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[2] Hosp Clin San Carlos, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [21] Extrapyramidal syndrome and long-acting injectable risperidone
    Hale, AS
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (04): : 756 - 757
  • [22] Long-acting injectable risperidone: Efficacy and safety
    Kane, JM
    Eerdekens, M
    Keith, SJ
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [23] Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
    Apostolos Aidonopoulos
    Anastasios Kanistras
    Anastasia Karastergiou
    Athanasios Karavatos
    Konstantinos Katsafouros
    Konstantinos Kontis
    Venetsanos Mavreas
    Maria Tzanakaki
    Nikolaos Tzavaras
    Errikos Tzebelikos
    Annals of General Psychiatry, 5 (Suppl 1)
  • [24] Obese patients with schizophrenia and schizoaffective disorder: Efficacy of injectable long-acting risperidone
    Permuy, RT
    Turner, MS
    Bouhours, P
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 175 - 175
  • [25] Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
    Lindenmayer, Jean-Pierre
    Khan, Anzalee
    SCHIZOPHRENIA RESEARCH, 2011, 125 (2-3) : 267 - 277
  • [26] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L.
    Lam, A.
    McCormick, J.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [27] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L
    Lam, A
    McCormick, J
    Luong, D
    Camacho, F
    VALUE IN HEALTH, 2005, 8 (06) : A202 - A203
  • [28] Haloperidol decanoate and long-acting injectable risperidone: subjective experience of outpatients with schizophrenia
    Dalmotto, M.
    Pirfo, E.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2010, 16 (03): : 299 - 304
  • [29] A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
    Pandina, Gahan
    Lane, Rosanne
    Gopal, Srihari
    Gassmann-Mayer, Cristiana
    Hough, David
    Remmerie, Bart
    Simpson, George
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (01): : 218 - 226
  • [30] Cognitive improvements in patients with schizophrenia with risperidone long-acting injectable: Relationship to functioning?
    Pandina, G
    Bilder, R
    Harvey, P
    Lasser, RA
    Rodriguez, S
    Turkoz, I
    Gharabawi, G
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 500 - 500
12345